Prognostic value of restless legs syndrome in hemodialysis patients: a systematic review and meta-analysis
Authors Li J, Zhang T, Shao Q
Received 19 March 2017
Accepted for publication 28 April 2017
Published 16 June 2017 Volume 2017:13 Pages 1569—1574
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Professor Wai Kwong Tang
Jing Li,1,* Tao Zhang,2,* Qingmiao Shao3
1Department of Transplantation, The First Central Hospital of Tianjin, 2Department of Nephrology, The First Affiliated Hospital of Tianjin Chinese Medical University, 3Department of Cardiology, The Second Hospital of Tianjin Medical University, Tianjin, People’s Republic of China
*These authors contributed equally to this work
Background: Previous studies have revealed that restless legs syndrome (RLS) not only is frequently prevalent in dialysis patients but also increases the risk of death in dialysis patients, especially in hemodialysis (HD) patients. However, inconsistent results also still exist, having attracted confusion and discussion. Owing to mixed and inconclusive results, we conducted to perform the comprehensive meta-analysis to evaluate the potential prognostic value of RLS in HD patients.
Materials and methods: We conducted a systematic literature search using electronic databases (PubMed, Ovid, Embase and Web of Science) to identify relevant studies reporting on all-cause mortality and cardiovascular (CV) events in HD patients suffering from RLS. We searched the literature published up to December 5, 2016, or earlier. We used both fixed- and random-effects models to calculate the overall effect estimate. An I2>50% indicates at least moderate statistical heterogeneity. A sensitivity analysis and subgroup analysis were performed to find the origin of heterogeneity.
Results: A total of four studies including 1,839 patients found that there was no significant association between RLS and all-cause mortality (hazard ratio [HR]: 1.649; 95% confidence interval [CI]: 0.778–3.496) and CV events (HR: 0.863; 95% CI: 0.600–1.127) in HD patients. Heterogeneity among the studies was observed for all-cause mortality (I2=80.7%, P=0.001).
Conclusion: Our meta-analysis suggests that there was no significant effect of RLS on all-cause mortality and CV events in HD patients. Therefore, large-scale and well-designed studies are needed to validate the association between RLS and the risk of death in HD patients.
Keywords: restless legs syndrome, hemodialysis, cardiovascular events, mortality, meta-analysis
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]